JAC Advance Access originally published online on April 14, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 51, 1213-1222
© 2003 The British Society for Antimicrobial Chemotherapy
Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey
1 Centre Hospitalier A. Mignot, Versailles; 2 Institut Pasteur, Paris; 3 Collège de Bactériologie-Virologie Hygiène des Hôpitaux, France
Received 22 November 2002; returned 21 January 2003; revised 30 January 2003; accepted 9 February 2003
All bloodstream strains, total 1463, isolated during a 1 month period in 105 hospitals representing all geographical areas in France were collected to study their antimicrobial susceptibility. The three major species were Escherichia coli, Staphylococcus aureus and coagulase-negative staphylococci. Among the 242 S. aureus, 87 were resistant to methicillin and among those 99% were resistant to ciprofloxacin, 11.5% to gentamicin, 1% to quinupristin/dalfopristin and 8% were heterogeneously resistant to vancomycin. Study of the methicillin-resistant S. aureus indicated that 12 clones had disseminated in French hospitals, six being heterogeneously resistant to vancomycin. Among the Streptococcus pneumoniae, 43% showed decreased susceptibility to the penicillins and 42% to erythromycin. One isolate was highly resistant to fluoroquinolones. Gentamicin, cefotaxime, ciprofloxacin and gatifloxacin resistance was rare in Enterobacteriaceae with 95% of strains susceptible. The incidence of extended-spectrum ß-lactamases was quite low. Moreover more than 25% of Pseudomonas aeruginosa strains were resistant to ciprofloxacin and gentamicin. The magnitude of antibiotic resistance in bloodstream isolates, in particular Gram-positive bacteria, emphasizes the importance of hospital control measures, rational prescribing policies and new vaccine strategies.
Keywords: bloodstream infection, antimicrobial susceptibility, VRSA, Streptococcus pneumoniae, France
* Corresponding author. Tel: +33-1-39-63-91-33; Fax: +33-1-39-63-93-12; E-mail: PALLOUCH{at}ch-versailles.fr
The ColBVH study group participants are listed in the Acknowledgements.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Galas, J.-W. Decousser, N. Breton, T. Godard, P. Y. Allouch, P. Pina, and and the College de Bacteriologie Virologie Hygiene Nationwide Study of the Prevalence, Characteristics, and Molecular Epidemiology of Extended-Spectrum-{beta}-Lactamase-Producing Enterobacteriaceae in France Antimicrob. Agents Chemother., February 1, 2008; 52(2): 786 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. E. E. Cleven, M. Palka-Santini, J. Gielen, S. Meembor, M. Kronke, and O. Krut Identification and characterization of bacterial pathogens causing bloodstream infections by DNA microarray. J. Clin. Microbiol., July 1, 2006; 44(7): 2389 - 2397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-W. Decousser, I. Methlouthi, P. Pina, A. Collignon, P. Allouch, and on behalf of the ColBVH Study Group New Real-Time PCR Assay Using Locked Nucleic Acid Probes To Assess Prevalence of ParC Mutations in Fluoroquinolone-Susceptible Streptococcus pneumoniae Isolates from France. Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1594 - 1598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Poole Aminoglycoside Resistance in Pseudomonas aeruginosa Antimicrob. Agents Chemother., February 1, 2005; 49(2): 479 - 487. [Full Text] [PDF]
|
|
|
|
|
|
N. van der Mee-Marquet, A.-S. Domelier, N. Girard, R. Quentin, and the Bloodstream Infection Study Group of the Relai Epidemiology and Typing of Staphylococcus aureus Strains Isolated from Bloodstream Infections J. Clin. Microbiol., December 1, 2004; 42(12): 5650 - 5657. [Abstract] [Full Text] [PDF]
|
|